SCHEMBL2367340

SCHEMBL2367340

COc1ccc(C(OCc2cc(CO)cc(-c3ccc4ccc5cccc6ccc3c4c56)c2)(c2ccccc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.33
PPARD Q03181 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
PPARG P37231 2/20 0.32
MAPT P10636 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
PPARA Q07869 1/20 0.32
POLB P06746 1/20 0.32
NCOA2 Q15596 1/20 0.32
NCOA1 Q15788 1/20 0.32
CTDSP1 Q9GZU7 1/20 0.32
NCOA3 Q9Y6Q9 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
C5AR1 P21730 1/20 0.32
GPR84 Q9NQS5 1/20 0.32
SLC6A1 P30531 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2367752 0.93 PPARG (0.34) BACE1PPARDPDE4APDE4BPDE4C
SCHEMBL2368004 0.89 PPARG (0.39) BACE1PPARDPPARGPPARAGPR84
SCHEMBL2367722 0.88 PPARG (0.43) BACE1PPARDPPARGMAPTPPARA
SCHEMBL2367563 0.81 BACE1 (0.42) BACE1PPARDPPARGMAPTPOLB
SCHEMBL12539335 0.78 RAB9A (0.43) SLC6A1SLC6A11KIF11
SCHEMBL16618219 0.77 CYP1A2 (0.38) BACE1SLC6A1SLC6A11KIF11
SCHEMBL19689391 0.77 KIF11 (0.38) SLC6A1SLC6A11KIF11
SCHEMBL19463046 0.77 KIF11 (0.43) SLC6A1SLC6A11KIF11
SCHEMBL12293558 0.76 CYP1A2 (0.41) PPARDPPARGMAPTPPARAPOLB
SCHEMBL16618237 0.75 MAOB (0.47) PPARDPDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366785-B1 OLIGONUCLEOTIDE DERIVATIVE, LABELING AGENT, AND USE OF THE LABELING AGENT JAPAN SCIENCE & TECH AGENCY (JP) 2013-01-16 EP disclosed
US-8354515-B2 Oligonucleotide derivative, labeling agent and use for labeling agent JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2013-01-15 US disclosed
US-20120126175-A1 OLIGONUCLEOTIDE DERIVATIVE, LABELING AGENT AND USE FOR LABELING AGENT JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2012-05-24 US disclosed
EP-2366785-A1 OLIGONUCLEOTIDE DERIVATIVE, LABELING AGENT, AND USE OF THE LABELING AGENT Japan Science And Technology Agency (JP) 2011-09-21 EP disclosed
WO-2010055789-A1 OLIGONUCLEOTIDE DERIVATIVE, LABELING AGENT, AND USE OF THE LABELING AGENT 独立行政法人科学技術振興機構 (JP) 2010-05-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120126175-A1 OLIGONUCLEOTIDE DERIVATIVE, LABELING AGENT AND USE FOR LABELING AGENT UPF1, SPIN4, SRRT BACE1 2216/4885PPARD 1715/4885PDE4A 4058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.